United States · FDA National Drug Code directory
RIZATRIPTAN BENZOATE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43817-135_28d0cbcc-59cc-7cf4-e063-6294a90a9b53
- Product NDC
- 43817-135
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- rizatriptan benzoate
- Labeler
- Panacea Biotec Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170117
- Source listing expiry
- 20261231
Source-listed ingredients
- RIZATRIPTAN BENZOATE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 BLISTER PACK in 1 CARTON (43817-135-04) / 3 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK (43817-135-03) · 43817-135-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →